The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening

Cancer

Volumn 125, Issue 4, 2019, Pages 515-523

  Tabár, László ^a   Dean, Peter B ^b   Chen, Tony Hsiu Hsi ^c   Yen, Amy Ming Fang ^d   Chen, Sam Li Sheng ^d   Fann, Jean Ching Yuan ^e   Chiu, Sherry Yueh Hsia ^f   Ku, May Mei Sheng ^c   Wu, Wendy Yi Ying ^g   Hsu, Chen Yang ^c   Chen, Yu Ching ^h   Beckmann, Kerri ⁱ   Smith, Robert A ^j   Duffy, Stephen W ^k  

^a FALUN HOSPITAL   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e KAINAN UNIVERSITY   (Taiwan)

^f CHANG GUNG UNIVERSITY   (Taiwan)

^g UMEÅ UNIVERSITY   (Sweden)

^h TAIPEI CITY HOSPITAL   (Taiwan)

ⁱ UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^j AMERICAN CANCER SOCIETY   (United States)

^k QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

more..

Author keywords

breast cancer; fatality; mammography; mortality; screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER THERAPY; CASE CONTROL STUDY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SWEDEN; BREAST TUMOR; EARLY CANCER DIAGNOSIS; FOLLOW UP; INCIDENCE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; PROGNOSIS; REGISTER; SURVIVAL RATE;

ADULT; AGED; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; PROGNOSIS; REGISTRIES; SURVIVAL RATE; SWEDEN;

EID: 85056150210     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.31840     Document Type: Article

References (35)

1. Jonsson H, Nystrom L, Tornberg S, Lenner P. Service screening with mammography of women aged 50–69 years in Sweden: effects on mortality from breast cancer. J Med Screen. 2001;8:152-160.
2. Jonsson H, Bordas P, Wallin H, Nystrom L, Lenner P. Service screening with mammography in northern Sweden: effects on breast cancer mortality—an update. J Med Screen. 2007;14:87-93.
3. Tabar L, Vitak B, Chen TH, et al. Swedish 2-County Trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260:658-663.
4. Toikkanen SP, Kujari HP, Joensuu H. Factors predicting late mortality from breast cancer. Eur J Cancer. 1991;27:586-591.
5. Joensuu H, Pylkkanen L, Toikkanen S. Late mortality from pT1N0M0 breast carcinoma. Cancer. 1999;85:2183-2189.
6. Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985;1:829-832.
7. IARC Working Group on the Evaluation of Cancer-Preventive Strategies. Breast Cancer Screening. Vol 15. Lyon, France: IARC Press; 2016.
8. Duffy SW, Cuzick J, Tabar L, et al. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programs. Appl Stat. 2002;51:234-243.
9. Socialstyrelsen (National Board of Health and Welfare). Nationella Riktlinjer for Brost-, Kolorektal- och Prostatacancervard 2007. Stockholm, Sweden: Ansvarigt Regionalt Cancercentrum; 2007.
10. Brostcancer Nationellt Vardprogram. Brostcancer Nationellt Vardprogram: Landstingens och Regionernas Nationella Samverkansgrupp Inom Cancervarden. Stockholm, Sweden: Ansvarigt Regionalt Cancercentrum; 2014.
11. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 US Preventive Services Task Force recommendation. Ann Intern Med. 2016;164:244-255.
12. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380:1778-1786.
13. Chen TH, Yen AM, Fann JC, et al. Clarifying the debate on population-based screening for breast cancer with mammography: a systematic review of randomized controlled trials on mammography with Bayesian meta-analysis and causal model [serial online]. Medicine (Baltimore). 2017;96:e5684.
14. Kelly SP, Rosenberg PS, Anderson WF, et al. Trends in the incidence of fatal prostate cancer in the United States by race. Eur Urol. 2017;71:195-201.
15. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004;42:793-806, v.
16. Tabar L, Yen AM, Wu WY, et al. Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J. 2015;21:13-20.
17. Broeders M, Moss S, Nystrom L, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012;19(suppl 1):14-25.
18. Pocobelli G, Weiss NS. Breast cancer mortality in relation to receipt of screening mammography: a case-control study in Saskatchewan, Canada. Cancer Causes Control. 2015;26:231-237.
19. Coldman A, Phillips N, Wilson C, et al. Pan-Canadian study of mammography screening and mortality from breast cancer [serial online]. J Natl Cancer Inst. 2014;106:dju261.
20. Yen AM, Tsau HS, Fann JC, et al. Population-based breast cancer screening with risk-based and universal mammography screening compared with clinical breast examination: a propensity score analysis of 1429890 Taiwanese women. JAMA Oncol. 2016;2:915-921.
21. Morrell S, Taylor R, Roder D, Robson B, Gregory M, Craig K. Mammography service screening and breast cancer mortality in New Zealand: a national cohort study 1999–2011. Br J Cancer. 2017;116:828-839.
22. Duffy SW, Chen TH, Smith RA, Yen AM, Tabar L. Real and artificial controversies in breast cancer screening: a perspective article. Breast Cancer Manage. 2013;2:519-528.
23. Kopans DB. The breast cancer screening “arcade” and the “whack-a-mole” efforts to reduce access to screening. Semin Ultrasound CT MR. 2018;39:2-15.
24. Moss SM, Nystrom L, Jonsson H, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen. 2012;19(suppl 1):26-32.
25. Nystrom L. The Swedish randomised controlled trial on mammography screening has been properly designed, conducted and analysed. J R Soc Med. 2015;108:429-430.
26. Njor S, Nystrom L, Moss S, et al. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen. 2012;19(suppl 1):33-41.
27. Welch HG. Screening mammography—a long run for a short slide? N Engl J Med. 2010;363:1276-1278.
28. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database [serial online]. BMJ. 2011;343:d4411.
29. Welch HG, Prorok PC, O'Malley AJ, Kramer BS. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med. 2016;375:1438-1447.
30. Autier P, Boniol M. Mammography screening: a major issue in medicine. Eur J Cancer. 2018;90:34-62.
31. Tabar L, Chen TH, Yen AM, et al. effect of mammography screening on mortality by histological grade. Cancer Epidemiol Biomarkers Prev. 2018;27:154-157.
32. Plevritis SK, Munoz D, Kurian AW, et al. Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000–2012. JAMA. 2018;319:154-164.
33. Chen HH. Contributions of screening and treatment to mortality from breast cancer. JAMA. 2018;319:2335-2336.
34. Malmgren JA, Parikh J, Atwood MK, Kaplan HG. Impact of mammography detection on the course of breast cancer in women aged 40–49 years. Radiology. 2012;262:797-806.
35. Health Council of the Netherlands. Population Screening for Breast Cancer: Expectations and Developments. The Hague, The Netherlands: Health Council of the Netherlands; 2014.